Tag: dry powder inhaler market overview

  • Future Outlook of the Dry Powder Inhaler Market: Growth, Trends, and Emerging Opportunities Explored

    Future Outlook of the Dry Powder Inhaler Market: Growth, Trends, and Emerging Opportunities Explored

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What is the Expected Growth Rate of the Dry Powder Inhaler Market Based on Industry Projections?

    The market size of dry powder inhalers has witnessed a significant surge in the recent past. It is projected to escalate from $21.25 billion in 2024 to $22.35 billion in 2025 with a compound annual growth rate (CAGR) of 5.2%. The expansion during the historical era was due to factors including revitalized enthusiasm in sustainable building materials, the importance placed on cultural preservation, and heritage restoration. The growth in enclosed construction practices, local purchasing, community participation, along with regulatory backing and building rules also contributed to this rise.

    The market size for dry powder inhalers is anticipated to experience consistent expansion in the forthcoming years. The market is forecasted to reach $27.13 billion by 2029 with a compound annual growth rate (CAGR) of 5.0%. Various factors, such as ongoing focus on sustainability, worldwide urbanization trends, enhancements in manufacturing processes, government incentives and policies, and global economic conditions are seen as key drivers for growth during the projected period. The future trends, which include escalated research and development efforts, reawakening interest in age-old building techniques, breakthroughs in material technology, trends in architecture and design, and regulatory endorsement of green construction, are significant in shaping the market.

    Which Factors Are Enhancing the Growth of the dry powder inhaler Market?

    The increase in respiratory illnesses is projected to stimulate the expansion of the dry powder inhaler market. These ailments, encompassing a vast range of conditions impacting the respiratory system, are effectively managed by dry powder inhalers, which are crucial for the treatment of diseases like asthma, COPD, and cystic fibrosis by channeling medication straight to the lung area. They present a viable alternative for the traditional treatment methods. As per a study released in December 2023 by JAMA Network Open, a journal from the American Medical Association, the global COPD burden could witness a rise of about 23% by 2050, amounting to around 600 million cases. Predictions show an expected 47.1% rise in female cases, while male instances are likely to increase by 9.4%. It is also projected that the most number of cases will be in low to middle income areas, where the occurrence rate is anticipated to double that of affluent regions by 2050. Hence, this rise in respiratory diseases is expected to bolster the dry powder inhaler market.

    Dry Powder Inhaler Market Driver: Effect of Increasing Air Pollution On The Growth Of Dry Powder Inhaler Market

     

    Explore Comprehensive Insights Into The Global Dry Powder Inhaler Market With A Free Sample Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13430&type=smp

    What Companies Are At the Forefront of Innovation in the Dry Powder Inhaler Market?

    Major companies operating in the dry powder inhaler market report are:

    • Novartis AG_x000D_

    • AstraZeneca plc._x000D_

    • GlaxoSmithKline PLC_x000D_

    • 3M Company_x000D_

    • Boehringer Ingelheim GmbH_x000D_

    How Are Emerging Trends in Consumer Behavior Affecting the Dry Powder Inhaler Market?

    Leading corporations in the dry powder inhaler market are working on groundbreaking products employing muscarinic antagonist, aimed to treat chronic obstructive pulmonary disease (COPD), hence diversifying their product range. Muscarinic antagonist is a medication that blocks the muscarinic acetylcholine receptor, effectively managing and treating conditions like COPD and organophosphate poisoning. For instance, Berry Global, an American enterprise recognized for creating and manufacturing an array of flexible packaging solutions, unveiled its latest dry powder inhaler at Pharma pack in March 2024. This inhaler is engineered to optimize drug application for respiratory disorders such as COPD and asthma, providing a tailor-made solution for pharmaceutical corporations.

    Secure Your Global Dry Powder Inhaler Market Report Now for Fast and Efficient Delivery!

    https://www.thebusinessresearchcompany.com/report/dry-powder-inhaler-global-market-report

    Which Primary Segments of the Dry Powder Inhaler Market Are Driving Growth and Industry Transformations?

    The dry powder inhaler market covered in this report is segmented –

    1) By Product: Single-Dose Inhalers, Multi-Dose Inhalers

    2) By Function: Manually Operated Inhaler Devices, Digitally Operated Inhaler Devices

    3) By Application: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, Other Applications

    4) By End User: Hospitals And Clinics, Homecare Settings, Ambulatory Surgical Centers, Other End Users

    Subsegments:

    1) By Single-Dose Inhalers: Capsule-Based Inhalers, Diskus-Based Inhalers

    2) By Multi-Dose Inhalers: Blister-Based Inhalers, Rotahaler-Based Inhalers

    What Regions Are Propelling Growth in the Dry Powder Inhaler Industry?

    North America was the largest region in the dry powder inhaler market in 2024. The regions covered in the dry powder inhaler market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    What Does the Definition of the Dry Powder Inhaler Market Include?

    A dry powder inhaler (DPI) refers to a medical device used for delivering medication directly to the lungs in the form of dry powder. It is designed to treat respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD). It is essential for the user to inhale rapidly and deeply to enable the medication to reach the lungs to utilize a DPI effectively.

    Browse Through More Similar Reports By The Business Research Company:

    Dry Bulk Materials Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/dry-bulk-materials-global-market-report

    Dry Eye Syndrome Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/dry-eye-syndrome-global-market-report

    Dry Milling Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/dry-milling-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • 2024-2033 Dry Powder Inhaler  Market: Key Insights on Growth Opportunities

    2024-2033 Dry Powder Inhaler Market: Key Insights on Growth Opportunities

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Rate of the Dry Powder Inhaler Market from 2024 to 2033?

    The dry powder inhaler market has shown strong growth, projected to expand from $20.18 billion in 2023 to $21.25 billion in 2024 at a CAGR of 5.3%. Key factors driving growth in prior years include renewed interest in sustainable materials, cultural preservation, green building practices, local sourcing, and regulatory support.

    The dry powder inhaler market is expected to grow steadily, reaching $25.82 billion by 2028 at a CAGR of 5.0%. This growth is driven by continued sustainability efforts, global urbanization, advancements in manufacturing processes, government policies, and global economic factors. Key trends include increased research and development, advancements in material technology, and regulatory support for sustainable construction.

    Claim Your Free Sample of the Global Dry Powder Inhaler Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13430&type=smp

    What Key Factors Are Fueling the Growth of the Dry Powder Inhaler Market?

    The increasing prevalence of respiratory diseases is expected to drive the growth of the dry powder inhaler market. Respiratory diseases encompass various conditions that affect the respiratory system. Dry powder inhalers are critical in treating respiratory conditions like asthma, COPD, and cystic fibrosis, delivering medicine directly to the lungs where it has the most impact. They offer a promising alternative to traditional drug delivery methods. For example, reports from the Australian Institute of Health and Welfare in June 2023 revealed an increase in respiratory disease-related deaths in Australia, from 43,031 in 2020 to 46,551 in 2021. This growing prevalence of respiratory diseases is expected to boost the dry powder inhaler market.

    What Are the Major Segments of the Dry Powder Inhaler Market?

    1) By Product: Single-Dose Inhalers, Multi-Dose Inhalers

    2) By Function: Manually Operated Inhaler Devices, Digitally Operated Inhaler Devices

    3) By Application: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, Other Applications

    4) By End User: Hospitals And Clinics, Homecare Settings, Ambulatory Surgical Centers, Other End Users

    What New Trends Are Transforming the Dry Powder Inhaler Market?

    Leading companies in the dry powder inhaler market are innovating with muscarinic antagonists to treat chronic obstructive pulmonary disease (COPD) and expand their product offerings. A muscarinic antagonist is a drug that blocks muscarinic acetylcholine receptors, helping manage diseases like COPD and organophosphate poisoning. For example, Glenmark Pharmaceuticals Limited launched Tiogiva in June 2021, a long-acting muscarinic antagonist DPI designed for COPD treatment in the UK. It is a bioequivalent of Boehringer-Ingelheim’s Spiriva Handihaler and works by relaxing the muscles in the airways to ease breathing. It is taken once a day and does not require a spacer.

    Order Now for Fast Delivery of Your Dry Powder Inhaler Market Report!

    https://www.thebusinessresearchcompany.com/report/dry-powder-inhaler-global-market-report

    Which Regions Are Driving Growth in the Dry Powder Inhaler Market?

    North America was the largest region in the dry powder inhaler market in 2023. The regions covered in the dry powder inhaler market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Dry Powder Inhaler Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the dry powder inhaler market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Dry Powder Inhaler Market Include

    1. Dry Powder Inhaler Market Executive Summary

    2. Dry Powder Inhaler Market Segments

    3. Dry Powder Inhaler Market Size And Template Market Growth Rate

    4. Key Dry Powder Inhaler Market Trends

    5. Major Dry Powder Inhaler Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Dry Powder Inhaler Market

    26. Top Dry Powder Inhaler Companies

    27. Dry Powder Inhaler Market Opportunities And Strategies

    28. Dry Powder Inhaler Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Dry Bulk Materials Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/dry-bulk-materials-global-market-report

    Household Laundry Equipment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/household-laundry-equipment-global-market-report

    Cast Resin Dry Type Transformer Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cast-resin-dry-type-transformer-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Key Trends And Drivers In The Dry Powder Inhaler Market 2024

    Key Trends And Drivers In The Dry Powder Inhaler Market 2024

    The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

    Market Growth Overview:

    • The dry powder inhaler market has experienced strong growth in recent years.
    • Expected to grow from $20.18 billion in 2023 to $21.25 billion in 2024 at a CAGR of 5.3%.
    • Forecasted to reach $25.82 billion in 2028 at a CAGR of 5.0%.

    Factors Driving Growth:

    • Rising prevalence of respiratory diseases.
    • Technological advancements in manufacturing processes.
    • Government incentives and policies supporting healthcare.
    • Global economic factors influencing market dynamics.

    Rising Prevalence Of Respiratory Diseases Fuels Growth

    Prevalence of Respiratory Diseases:

    • Respiratory diseases encompass a broad category of medical conditions affecting the respiratory system.
    • Conditions include asthma, COPD, cystic fibrosis, among others.

    Impact on Market:

    • Dry powder inhalers deliver medicine directly to the lungs, providing effective treatment.
    • Rise in respiratory disease-related deaths drives market growth.

    Read More On The Dry Powder Inhaler Market Report 2024 – https://www.thebusinessresearchcompany.com/report/dry-powder-inhaler-global-market-report

    Major Players in the Market

    Key Companies:

    • Novartis AG
    • AstraZeneca plc.
    • GlaxoSmithKline PLC
    • Boehringer Ingelheim GmbH
    • Catalent Inc.
    • And many more…

    Innovations in Dry Powder Inhalers:

    • Development of muscarinic antagonist drugs for COPD treatment.
    • Launch of long-acting muscarinic antagonist dry powder inhalers.
    • Acquisitions to enhance DPI manufacturing capabilities.

    Catalent Inc. Enhances DPI Manufacturing Capabilities

    Strategic Acquisition:

    • Catalent Inc. acquires Acorda Therapeutics Inc. to expand DPI manufacturing capabilities.
    • Adds commercial-stage products to portfolio for respiratory and neurological diseases.

    Market Segmentation and Regional Analysis

    Market Segments:

    1. Product: Single-Dose Inhalers, Multi-Dose Inhalers
    2. Function: Manually Operated, Digitally Operated
    3. Application: Asthma, COPD, Cystic Fibrosis, Other Applications
    4. End User: Hospitals, Homecare Settings, Ambulatory Surgical Centers

    Regional Insights:

    • North America leads the market, with significant growth potential in other regions.

    Conclusion

    The dry powder inhaler market is witnessing steady growth, driven by the rising prevalence of respiratory diseases and advancements in treatment options. Major players are focusing on innovation and strategic acquisitions to expand their product portfolios and manufacturing capabilities. With continued emphasis on healthcare and technological advancements, the market is poised for further expansion in the coming years, revolutionizing respiratory healthcare worldwide

    Request for A Sample Of The Global Dry Powder Inhaler Market Report:
    https://www.thebusinessresearchcompany.com/sample_request?id=13430&type=smp